"Mastocytosis, Systemic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.
Concept/Terms
Mastocytosis, Systemic- Mastocytosis, Systemic
- Mastocytoses, Systemic
- Systemic Mastocytoses
- Systemic Mastocytosis
- Systemic Mast-Cell Disease
- Mast-Cell Disease, Systemic
- Mast-Cell Diseases, Systemic
- Systemic Mast Cell Disease
- Systemic Mast-Cell Diseases
Indolent Systemic Mastocytosis- Indolent Systemic Mastocytosis
- Indolent Systemic Mastocytoses
- Mastocytoses, Indolent Systemic
- Mastocytosis, Indolent Systemic
- Systemic Mastocytoses, Indolent
- Systemic Mastocytosis, Indolent
Aggressive Systemic Mastocytosis- Aggressive Systemic Mastocytosis
- Aggressive Systemic Mastocytoses
- Mastocytoses, Aggressive Systemic
- Mastocytosis, Aggressive Systemic
- Systemic Mastocytoses, Aggressive
- Systemic Mastocytosis, Aggressive
Below are MeSH descriptors whose meaning is more general than "Mastocytosis, Systemic".
Below are MeSH descriptors whose meaning is more specific than "Mastocytosis, Systemic".
This graph shows the total number of publications written about "Mastocytosis, Systemic" by people in Harvard Catalyst Profiles by year, and whether "Mastocytosis, Systemic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 1 | 2 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 3 | 0 | 3 |
| 2014 | 5 | 0 | 5 |
| 2015 | 3 | 1 | 4 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 1 | 3 |
| 2018 | 6 | 0 | 6 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
Below are the most recent publications written about "Mastocytosis, Systemic" by people in Profiles.
-
mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis. J Allergy Clin Immunol. 2021 03; 147(3):877-878.
-
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions. J Allergy Clin Immunol. 2020 08; 146(2):300-306.
-
Introduction to a review series on rare systemic hematologic disorders. Blood. 2020 04 16; 135(16):1305.
-
Detection of KIT D816V in peripheral blood of children with manifestations of cutaneous mastocytosis suggests systemic disease. Br J Haematol. 2018 12; 183(5):775-782.
-
Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 12; 16(12):1500-1537.
-
Are Enterocolic Mucosal Mast Cell Aggregates Clinically Relevant in Patients Without Suspected or Established Systemic Mastocytosis? Am J Surg Pathol. 2018 10; 42(10):1390-1395.
-
The Mastocytosis Society Survey on Mast Cell Disorders: Part 2-Patient Clinical Experiences and Beyond. J Allergy Clin Immunol Pract. 2019 04; 7(4):1157-1165.e6.
-
Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. Blood Adv. 2018 02 27; 2(4):444-453.
-
A Case of Cryptogenic Liver Failure. Gastroenterology. 2018 07; 155(1):23-24.e1.
-
Identification of alpha-gal sensitivity in patients with a diagnosis of idiopathic anaphylaxis. Allergy. 2018 05; 73(5):1131-1134.